Galaxy Diagnostics, Inc. specializes in advanced testing solutions designed to detect elusive flea- and tick-borne pathogens, specifically *Bartonella* species, which are often missed by standard diagnostic methods. By enhancing clinical detection, the company aims to improve patient outcomes and strengthen the connection between human and animal health.
Company Values
Galaxy Diagnostics stands out for its proprietary Bartonella Digital ePCR™ Platform, which significantly increases diagnostic sensitivity for difficult-to-detect infections.